Effects of Alcohol Consumption on Hepatocarcinogenesis in Japanese Patients With Fatty Liver Disease

被引:32
作者
Kawamura, Yusuke [1 ,2 ,3 ]
Arase, Yasuji [1 ,2 ,4 ]
Ikeda, Kenji [1 ,2 ]
Akuta, Norio [1 ,2 ]
Kobayashi, Masahiro [1 ,2 ]
Saitoh, Satoshi [1 ,2 ]
Suzuki, Fumitaka [1 ,2 ]
Suzuki, Yoshiyuki [1 ,2 ]
Inao, Mie [3 ]
Mochida, Satoshi [3 ]
Kumada, Hiromitsu [1 ,2 ]
机构
[1] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan
[2] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan
[3] Saitama Med Univ, Fac Med, Dept Gastroenterol & Hepatol, Saitama, Japan
[4] Toranomon Gen Hosp, Hlth Management Ctr, Tokyo, Japan
关键词
NAFLD; AFLD; Liver Cancer; Asia; TERM-FOLLOW-UP; OBSTRUCTIVE SLEEP-APNEA; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; POPULATION; PREVALENCE; DIAGNOSIS; OBESITY; CANCER;
D O I
10.1016/j.cgh.2015.11.019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: The effect of ethanol consumption on hepatocarcinogenesis in patients with fatty liver disease (FLD) is not clear. We aimed to investigate the influence of alcohol consumption on hepatocarcinogenesis and determine the risk factors for hepatocellular carcinoma (HCC) in a large number of Japanese patients with FLD without viral hepatitis. METHODS: This multicenter, retrospective cohort study was conducted at a specialized center for hepatology in Japan and included 9959 patients with FLD without viral hepatitis, diagnosed by ultrasonography from January 1997 through December 2011. The patients' level of ethanol consumption was divided into 4 categories: <20 g/day (n = 6671), 20-39 g/day (n = 753), 40-69 g/day (n = 1589), and >= 70 g/day (n = 946). The primary endpoint was the onset of HCC. Statistical analyses performed included the Kaplan-Meier method and Cox proportional hazard analysis. The median follow-up period was 5.4 years. RESULTS: Of the study cohort, 49 cases (0.49%) developed HCC during the follow-up period. The annual incidence rate of HCC was 0.05% in patients with FLD and a daily ethanol consumption <20 g/day. Increasing levels of ethanol consumption were associated with increased annual incidence rates of HCC: 0.06% for patients with 20-39 g/day ethanol consumption (hazard ratio [HR], 1.54; 95% confidence interval [CI], 0.34-7.04), 0.16% for patients with 40-69 g/day ethanol consumption (HR, 3.49; 95% CI, 1.50-8.12), and 0.22% for patients with >= 70 g/day ethanol consumption (HR, 10.58; 95% CI, 5.06-22.13), compared with patients with ethanol consumption <20 g/day. Multivariate analysis showed that ethanol consumption >= 40 g/day was an independent risk factor for HCC: for 40-69 g/day the HR was 2.48 (95% CI, 1.01-6.05; P < .047) and for >= 70 g/day the HR was 12.61 (95% CI, 5.68-28.00; P < .001). CONCLUSIONS: Based on a multicenter, retrospective analysis of almost 10,000 patients with FLD, ethanol consumption >= 40 g/day is an independent risk factor for HCC.
引用
收藏
页码:597 / 605
页数:9
相关论文
共 33 条
[1]   The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]   Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction [J].
Adams, LA ;
Feldstein, A ;
Lindor, KD ;
Angulo, P .
HEPATOLOGY, 2004, 39 (04) :909-914
[3]   How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? [J].
Amarapurkar, Deepak N. ;
Hashimoto, Estsuko ;
Lesmana, Laurentius A. ;
Sollano, Jose D. ;
Chen, Pei-Jer ;
Goh, Khean-Lee .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) :788-793
[4]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[5]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[6]   Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease [J].
Arase, Yasuji ;
Suzuki, Fumitaka ;
Ikeda, Kenji ;
Kumada, Hiromitsu ;
Tsuji, Hiroshi ;
Kobayashi, Tetsuro .
JOURNAL OF GASTROENTEROLOGY, 2009, 44 (10) :1064-1070
[7]   Associations between beer, wine, and liquor consumption and lung cancer risk: A meta-analysis [J].
Chao, Chun .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (11) :2436-2447
[8]   Long-term follow-up of patients with NAFLD and elevated liver enzymes [J].
Ekstedt, Mattias ;
Franzen, Lennart E. ;
Mathiesen, Ulrik L. ;
Thorelius, Lars ;
Holmqvist, Marika ;
Bodemar, Goran ;
Kechagias, Stergios .
HEPATOLOGY, 2006, 44 (04) :865-873
[9]   Epidemiology of non-alcoholic fatty liver disease in China [J].
Fan, Jian-Gao ;
Farrell, Geoffrey C. .
JOURNAL OF HEPATOLOGY, 2009, 50 (01) :204-210
[10]   DESIGNS FOR GROUP SEQUENTIAL-TESTS [J].
FLEMING, TR ;
HARRINGTON, DP ;
OBRIEN, PC .
CONTROLLED CLINICAL TRIALS, 1984, 5 (04) :348-361